Amgen vs Cue Biopharma, .
Amgen vs Cue Biopharma, ., compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amgen is on 34/100 and Cue Biopharma, . on 62/100.
Where each one leads
Amgen
- domain rating: 80/100 against 34/100
- headcount: 39,919 against 38
- funding raised: $40.0M against $10.0M
- LinkedIn following: 1,697,311 against 5,297
Cue Biopharma, .
- our overall score: 62/100 against 34/100
At a glance
| Measure | Amgen | Cue Biopharma, . |
|---|---|---|
| What it is | A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics. | Developing engineered biologics to harness the immune system for disease treatment. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Immunotherapy, Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Biotech |
| Founded | 1980 | 2017 |
| Headquarters | Thousand Oaks, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Amgen | Cue Biopharma, . |
|---|---|---|
| Employees | 39,919 | 38 |
| Total funding | $40.0M | $10.0M |
| Latest round | IPO | Seed |
| LinkedIn followers | 1,697,311 | 5,297 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amgen | Cue Biopharma, . |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 62/100 |
| Traction | 58/100 | Not published |
| Team | 70/100 | 60/100 |
| Community | 8/100 | Not published |
| Search visibility | 68/100 | 67/100 |
| Quality | 15/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 80/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Amgen | Cue Biopharma, . |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | CloudFront | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Tailwind CSS |
| Analytics | Google Tag Manager | Google Analytics 4 |
Amgen vs Cue Biopharma, .: common questions
Which is better, Amgen or Cue Biopharma, .?
On our 0-100 score Cue Biopharma, . rates higher (62/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Amgen and Cue Biopharma, . compare on the numbers?
Amgen leads on domain rating (80/100 against 34/100), headcount (39,919 against 38), funding raised ($40.0M against $10.0M), LinkedIn following (1,697,311 against 5,297). Cue Biopharma, . leads on our overall score (62/100 against 34/100).
Read the full Amgen review and pricing or the Cue Biopharma, . review and pricing. You can also browse other Amgen alternatives we track.